智通财经APP讯，康宁杰瑞制药-B(09966)发布公告，于2026年4月23日(授出日期)，根据限制性股份奖励计划，本公司决议向两名合资格参与者(奖励承授人)(彼等为本集团雇员)授出合共 25万股奖励股份(奖励股份)，以认购最多合共25万股每股面值0.000002 美元的本公司普通股(股份)，惟须待奖励承授人接纳后方可作实。
更多港股重磅资讯，下载智通财经app
更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.